According to the Zhitong Finance App, Zhongsheng Beikong Biotechnology (08247) announced the results for the year ended December 31, 2023, with operating income of about 289.1 million yuan (RMB, same below), a year-on-year decrease of about 22.5%; loss attributable to parent company owners was 11.648 million yuan, profit of 8.106 million yuan for the same period last year; basic loss per share was 0.080 yuan.

In the current year, operating income decreased by about 22.5% year-on-year, mainly due to declining market demand due to changes in domestic and foreign public health prevention and control policies, and product prices falling due to centralized procurement in the industry.